Literature DB >> 25023776

Unfractionated heparin suppresses lipopolysaccharide-induced monocyte chemoattractant protein-1 expression in human microvascular endothelial cells by blocking Krüppel-like factor 5 and nuclear factor-κB pathway.

Xu Li1, Xin Li1, Zhen Zheng1, Yina Liu1, Xiaochun Ma2.   

Abstract

Unfractionated heparin (UFH) and low-molecular-weight heparins (LMWH), apart from anticoagulant activities, contain a variety of biological properties such as anti-inflammatory actions possibly affecting sepsis. Chemokines are vital for promoting the movement of circulating leukocytes to the site of infection and are involved in the pathogenesis of sepsis. The purpose of this study was to investigate the effects and potential mechanisms of UFH on lipopolysaccharide (LPS)-induced chemokine production in human pulmonary microvascular endothelial cells (HPMECs). HPMECs were pretreated with UFH (0.1 U/ml and 1 U/ml), 15 min prior to stimulation with LPS (10 μg/ml). Cells were cultured under various experimental conditions for 2 h and 6 h for analysis. UFH markedly decreased LPS-induced interleukin (IL)-8 and monocyte chemoattractant protein-1 (MCP-1) mRNA and protein expression in HPMECs. UFH also attenuated the secretion of these chemokines in culture supernatants. In addition, UFH blocked the chemotactic activities of LPS-stimulated HPMECs supernatants on monocytes migration as expected. UFH inhibited LPS-induced Krüppel-like factor 5 (KLF-5) mRNA and protein levels. Concurrently, UFH reduced nuclear factor (NF)-κB nuclear translocation. Importantly, transfection with siRNA targeting KLF-5 reduced NF-κB activation and chemokines expression. These results demonstrate that interfering with KLF-5 mediated NF-κB activation might contribute to the inhibitory effects of chemokines and monocytes migration by UFH in LPS-stimulated HPMECs.
Copyright © 2014 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Endothelial cells; Krüppel-like factor 5; Monocyte chemoattractant protein-1; Nuclear factor-κB; Sepsis; Unfractionated heparin

Mesh:

Substances:

Year:  2014        PMID: 25023776     DOI: 10.1016/j.imbio.2014.06.005

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  6 in total

1.  Unfractionated heparin protects the protein C system against lipopolysaccharide-induced damage in vivo and in vitro.

Authors:  Dongmei Zhao; Renyu Ding; Yina Liu; Xiaohan Yin; Zhidan Zhang; Xiaochun Ma
Journal:  Exp Ther Med       Date:  2017-09-29       Impact factor: 2.447

2.  Unfractionated heparin attenuates intestinal injury in mouse model of sepsis by inhibiting heparanase.

Authors:  Song Chen; Xiaojuan Zhang; Yini Sun; Ziwei Hu; Siyu Lu; Xiaochun Ma
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

3.  Unfractionated Heparin Attenuated Histone-Induced Pulmonary Syndecan-1 Degradation in Mice: a Preliminary Study on the Roles of Heparinase Pathway.

Authors:  Sifeng Fu; Sihan Yu; Yilin Zhao; Xiaochun Ma; Xu Li
Journal:  Inflammation       Date:  2021-10-16       Impact factor: 4.092

4.  Lipopolysaccharide pretreatment increases protease-activated receptor-2 expression and monocyte chemoattractant protein-1 secretion in vascular endothelial cells.

Authors:  Hung-Hsing Chao; Po-Yuan Chen; Wen-Rui Hao; Wei-Ping Chiang; Tzu-Hurng Cheng; Shih-Hurng Loh; Yuk-Man Leung; Ju-Chi Liu; Jin-Jer Chen; Li-Chin Sung
Journal:  J Biomed Sci       Date:  2017-11-15       Impact factor: 8.410

5.  Different signaling pathways involved in the anti-inflammatory effects of unfractionated heparin on lipopolysaccharide-stimulated human endothelial cells.

Authors:  Xu Li; Lu Li; Yuequan Shi; Sihan Yu; Xiaochun Ma
Journal:  J Inflamm (Lond)       Date:  2020-02-10       Impact factor: 4.981

6.  Unfractionated heparin improves the clinical efficacy in adult sepsis patients: a systematic review and meta-analysis.

Authors:  Sifeng Fu; Sihan Yu; Liang Wang; Xiaochun Ma; Xu Li
Journal:  BMC Anesthesiol       Date:  2022-01-21       Impact factor: 2.217

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.